Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration)

Summary

To investigate the safety, pharmacokinetics and pharmacodynamics of TS-143 when administered 3 times a day for 10 days to healthy Japanese adult males using placebo-controlled, double-blind, dose escalation study design.

Timeline

Start

2017-04-03

Primary completion

2017-07-07

Completion

2017-07-07

Drugs

Indications

No indication recorded.